NATCO Pharma Limited
NSE: NATCOPHARM.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Rajeev Nannapaneni
- Employees
- 4,016
- Headquarters
- Hyderabad, India
- IPO year
- 1996
- Market cap
- ₹210.4B
- Website
- https://www.natcopharma.co.in
Loading NATCOPHARM…
Loading profile data…Frequently asked questions about NATCOPHARM
What does NATCO Pharma Limited (NATCOPHARM.NS) do?
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central...
Where does NATCOPHARM.NS trade?
NATCO Pharma Limited (NATCOPHARM.NS) trades on the National Stock Exchange of India.
What sector is NATCOPHARM.NS in?
NATCO Pharma Limited (NATCOPHARM.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of NATCO Pharma Limited?
Rajeev Nannapaneni is the chief executive officer of NATCO Pharma Limited (NATCOPHARM.NS).
Where is NATCO Pharma Limited headquartered?
NATCO Pharma Limited is headquartered in India.
Does NATCOPHARM.NS pay a dividend?
Yes — NATCO Pharma Limited (NATCOPHARM.NS) paid a trailing twelve-month dividend of INR 5.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did NATCOPHARM.NS go public?
NATCO Pharma Limited (NATCOPHARM.NS) completed its initial public offering in 1996.